Bradley van Paridon

To what extent are asthma and COPD medicines defined as essential by WHO affordable and available in low/middle income countries? A systematic review explores this topic.

In patients critically ill with COVID-19, what are the determinants of nitrogen balance and what is the association between nitrogen balance trajectories and outcomes?

How do COVID-19 outcomes — such as mortality and disease severity — differ among lung transplant recipients who contracted COVID-19 earlier vs later in the pandemic?

Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?

Which prognostic models or indicators effectively predict critical care outcomes among patients hospitalized for COVID-19 pneumonia?

Researchers evaluated inflammatory biomarkers among patients with HIV who switched from a 3-drug antiretroviral therapy regimen to a 2-drug regimen of dolutegravir plus lamivudine.

Researchers evaluated different durations of fexinidazole treatment in patients with Chagas disease.

Researchers assessed the safety and effectiveness of twice-daily dolutegravir dosing plus rifampicin in children with HIV-associated tuberculosis infection.

Should clofazimine remain a “second-choice agent” for treating patients with multidrug-resistant tuberculosis? A meta-analysis reviews the current evidence.

Researchers assessed the duration of protection conferred by vaccination against yellow fever among healthy adults and children and those with immunocompromised conditions.

Researchers assessed the effect of triple therapy with ribavirin plus sofosbuvir and daclatasvir on sustained virologic response achievement in patients with hepatitis C complicated by cirrhosis.

Researchers compared patient satisfaction with telemedicine visits conducted via phone vs video.

Researchers evaluated the risk for stroke 30 days following herpes zoster infection and the effect of prior varicella zoster virus vaccination on stroke risk.

Researchers assessed immune responses among patients with systemic autoimmune diseases following receipt of a COVID-19 vaccine booster dose.

Researchers assessed the associated effectiveness, safety, and adherence of daily HIV pre-exposure prophylaxis (PrEP) vs on-demand PrEP.

Researchers assessed the safety and efficacy of the QazCovid-in COVID-19 vaccine.

Researchers assessed whether motivational interviews delivered by physicians increase antiretroviral therapy adherence among patients disengaged from HIV care.

Researchers compared the sensitivity and specificity between 3 cellular tests for Lyme disease.

Researchers investigated the effect of intrapartum antibiotic prophylaxis on cesarean delivery rates in women with obesity.

Researchers assessed the diagnostic accuracy of nanopore sequencing for the early identification of pulmonary tuberculosis.

Researchers compared mortality outcomes among patients with HIV infection receiving integrase strand transfer inhibitor-based antiretroviral therapy (ART) compared with those receiving other ART regimens.

Researchers developed a model to compare the performance and protective effects of 2 different vaccines against infections caused by varicella-zoster virus.

Researchers assessed antibody responses among health care workers 9 months after COVID-19 vaccination.

Researchers assessed the efficacy of COVID-19 vaccination among patients with cancer.

Researchers assessed the association between dexamethasone treatment and the occurrence of superinfections among patients with severe COVID-19.

Researchers assessed the safety and immunogenicity of Nanocovax, a novel COVID-19 vaccine candidate.

Researchers assessed the incidence of pneumocystis pneumonia among individuals in Germany between 2014 and 2019.

Researchers assessed the effects of sofosbuvir/ledipasvir vs nitazoxanide when added to standard care for the treatment of mild to moderate COVID-19.

Researchers assessed variations among clinical practice guidelines on the management of COVID-19 in children.

Researchers assessed morbidity and mortality outcomes following surgical resection for nonsmall cell lung cancer among patients with and without prior COVID-19 pneumonia.